StonvexLoading…
StonvexStonvexStonvexCore line items from DBVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.64M | $4.15M | $15.73M | $4.84M |
Operating Income | $-147.06M | $-116.59M | $-76.43M | $-96.63M |
Net Income | $-146.95M | $-113.92M | $72.71M | $96.27M |
EPS (Diluted) | $-1.05 | $-1.17 | $-0.76 | $-1.24 |
Total Assets | $233.72M | $65.66M | $182.99M | $246.52M |
Total Liabilities | $64.95M | $38.27M | $42.80M | $52.06M |
Cash & Equivalents | $194.17M | $32.46M | $141.37M | $209.19M |
Free Cash Flow OCF − CapEx | $-121.71M | $-106.81M | $-80.33M | $-56.42M |
Shares Outstanding | 139.57M | 102.85M | 95.12M | 77.38M |